Nasopharyngeal cancer

Disease1 paper

In silico1

Trial sponsors

Roche
Company1 trialPhase 245 people
Takeda
Company1 trialPhase 1/261 people
Sun Yat-sen University
5 trialsPhase 31,894 people
Sun Yat-Sen University Cancer Center
1 trialPhase 3580 people
Shantou University Medical College
1 trialPhase 3116 people
Chinese University of Hong Kong
1 trialPhase 3104 people
German Society for Pediatric Oncology and Hematology GPOH gGmbH
1 trialPhase 257 people
Samsung Medical Center
1 trialPhase 251 people

Latest

2

The Lancet Regional Health Western PacificReview4 Sep

Infection-driven cancers in Asia: implications from epidemiological transitions

Tobacco ControlIn silico3 Sep

MPOWER policy intensity and the global burden of smoking-attributable respiratory cancers: lag-aligned inequality regressions with Bayesian age-period-cohort projections (1990-2050)